D.C. Drug Pricing Law Dies, Again

Law360, New York (October 30, 2007, 12:00 AM EDT) -- On Tuesday, the U.S. Court of Appeals for the Federal Circuit hammered what may be the final nail into the coffin of a District of Columbia law that would have regulated the price of patented drugs in the U.S. capital.

Thirteen judges of the U.S. Court of Appeals for the Federal Circuit — a majority of that circuit court's jurists — refused to rehear as a full court an appeal of an August decision by a three-judge panel of the Federal Circuit invalidating the ordinance....
To view the full article, register now.

Law360 UK

UK Financial Services

Read Our Latest UK Legal News & Analysis

Financial Services Law360 UK and Insurance Law360 UK provide breaking news and in-depth analysis on U.K. and European Union regulation, enforcement, legislation, and litigation involving banks, investment firms, insurers, and more.